Share
Journal Information
Issue
Vol. 32. Issue S4.Carbapenemase-producing Enterobacteriaceae in the clinical practice
Pages 1-66 (December 2014)
Carbapenemase-producing Enterobacteriaceae: The end of the antibiotic era?
Álvaro Pascual, Vicente Pintado, Jesús Rodríguez-Baño, José María Miró
Enferm Infecc Microbiol Clin. 2014;32 Supl 4:1-3
Full text access
Open Article
Carbapenemases in Enterobacteriaceae: Types and molecular epidemiology
Luis Martínez-Martínez, Juan José González-López
Enferm Infecc Microbiol Clin. 2014;32 Supl 4:4-9
Full text access
Open Article
Epidemiology of infections caused by carbapenemase-producing Enterobacteriaceae: Reservoirs and transmission mechanisms
Lorena López-Cerero, Benito Almirante
Enferm Infecc Microbiol Clin. 2014;32 Supl 4:10-6
Full text access
Open Article
Evolution of carbapenemase-producing Enterobacteriaceae at the global and national level: What should be expected in the future?
Jesús Oteo, Elisenda Miró, María Pérez-Vázquez, Ferran Navarro
Enferm Infecc Microbiol Clin. 2014;32 Supl 4:17-23
Full text access
Open Article
Detection of carbapenemase-producing Enterobacteriaceae in various scenarios and health settings
Germán Bou, Jordi Vila, Cristina Seral, F. Javier Castillo
Enferm Infecc Microbiol Clin. 2014;32 Supl 4:24-32
Full text access
Open Article
Breakpoints for carbapenemase-producing Enterobacteriaceae: Is the problem solved?
Rafael Cantón, Andrés Canut, María Isabel Morosini, Antonio Oliver
Enferm Infecc Microbiol Clin. 2014;32 Supl 4:33-40
Full text access
Open Article
Infections caused by carbapenemase-producing Enterobacteriaceae: Risk factors, clinical features and prognosis
José Ramón Paño Pardo, Sergio Serrano Villar, Juan Carlos Ramos Ramos, Vicente Pintado
Enferm Infecc Microbiol Clin. 2014;32 Supl 4:41-8
Full text access
Open Article
Treatment of infections caused by carbapenemase-producing Enterobacteriaceae
Jesús Rodríguez-Baño, José Miguel Cisneros, Carlota Gudiol, José Antonio Martínez
Enferm Infecc Microbiol Clin. 2014;32 Supl 4:49-55
Full text access
Open Article
Future alternatives for the treatment of infections caused by carbapenemase-producing Enterobacteriaceae: What is in the pipeline?
Juan Pablo Horcajada, Julián Torre-Cisneros, Carmen Peña, María Carmen Fariñas
Enferm Infecc Microbiol Clin. 2014;32 Supl 4:56-60
Full text access
Open Article
Control strategies for carbapenemase-producing Enterobacteriaceae at different levels of the healthcare system
Ángel Asensio, Mireia Cantero, Evelyn Shaw, Salvador Vergara-López
Enferm Infecc Microbiol Clin. 2014;32 Supl 4:61-6
Full text access
Open Article
Publish in
Enfermedades Infecciosas y Microbiología Clínica
La Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica agradece la colaboración de:
SOCIOS PROTECTORES
-
- Pfizer GEP, S.L.U.
- Shionogi, S.L.U.
- AbbVie Spain, S.L.U.
- Gilead Sciences, S.L.U.
- Vircell Spain, S.L.U.
- Roche Diagnostics, S.L.U.
- ASTRAZENECA FARMACÉUTICA SPAIN, S.A.
- Qiagen Iberia S.L.
- Laboratorios ViiV Healthcare, S.L.
SOCIOS PATROCINADORES
- Becton Dickinson S.A.U.
- Janssen-Cilag, S.A.
- Angelini Farmacéutica, S.A.
- Biomerieux España, S,A.U.
- Merck Sharp & Dohme de España, S.A.
- Hologic Iberia, S.L.U.
- Laboratorios Menarini S.A.
- Accelerate Diagnostics S.L.
- Abbott Laboratories, S.A.
- Cepheid Iberia S.L.U.
- Illumina Productos de España. S.L.U.
- DiaSorin Iberia, S.A.
- GlaxoSmithKline, S.A.
- Sysmex España S.L.
Enfermedades Infecciosas y Microbiología Clínica follows the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals